Annals of Allergy Asthma & Immunology

Papers
(The H4-Index of Annals of Allergy Asthma & Immunology is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
A coronavirus disease 2019–vaccinated patient with phosphoinositide 3-kinase disease with mild illness after severe acute respiratory syndrome coronavirus 2 infection168
Update in primary immune deficiencies for the practicing allergist/clinical immunologist166
Asthma, in quest of optimizing care154
ATYPICAL MANIFESTATIONS OF DRESS SYNDROME WITHOUT EOSINOPHILIA. CASE REPORT92
A CASE OF ANAPHYLAXIS TO KETOROLAC IN A PEDIATRIC PATIENT85
CHARACTERIZING PEDIATRIC NATIVE AMERICAN PATIENTS WITH EOSINOPHILIC GASTROINTESTINAL DISEASE AT A SINGLE TERTIARY CARE CENTER83
DRUG ALLERGY OR MAST CELL ACTIVATION?82
ASSESSING OUTCOMES OF A DEDICATED REFERRAL PATHWAY FOR EVALUATION OF PENICILLIN ALLERGY DURING PREGNANCY80
UNPREDICTABLE AIRWAY COLLAPSE! A CASE OF ACQUIRED ANGIOEDEMA ASSOCIATED WITH B-CELL LYMPHOMA.68
SAFE ADMINISTRATION OF GCSF AFTER GRADED CHALLENGE IN PATIENT WITH DELAYED CUTANEOUS DRUG HYPERSENSITIVITY REACTION64
A CASE OF AUTO-INFLAMMATORY DISEASE MIMICKING IMMUNODEFICIENCY55
UNIQUE PRESENTATION OF HYPEREOSINOPHILIC SYNDROME IN THE POSTPARTUM PERIOD WITH ATYPICAL FEATURES AND THERAPEUTIC CHALLENGES53
A NOVEL CASE OF FPIES AFTER PINE NUT FOOD CHALLENGE IN AN 18-YEAR-OLD FEMALE53
Editorial Board52
13.2 MG INTRANASAL EPINEPHRINE TREATMENT IN CONGESTION SHOWS INCREASED BIOAVAILABILITY WITHOUT PHARMACOKINETIC AND PHARMACODYNAMIC CORRELATION49
AMELIORATION OF SEVERE EXTRAGENITAL WARTS USING HPV VACCINATION: CASE REPORT AND SURVEY OF THE LITERATURE49
Consideration of pulmonary hypertension in the evaluation of common variable immunodeficiency47
Disparity between mold immunotherapy dosing and practice parameter recommendations in a large healthcare setting47
RARE MUTATION IN AIRE GENE IDENTIFIED IN PATIENT WITH VERY EARLY ONSET IBD46
POST THYMECTOMY: AN EXAMPLE OF IMMUNE DYSREGULATION?45
A NOVEL PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT VARIANT IDENTIFIED IN T-B-NK+ SEVERE COMBINED IMMUNODEFICIENCY42
APPROACHING THE STIFF UPPER LIP: A CASE OF PSEUDOANGIOEDEMA DIAGNOSED AS OROFACIAL GRANULOMATOSIS41
OMALIZUMAB: A POTENTIAL LONG-TERM THERAPEUTIC ALTERNATIVE FOR REFRACTORY DELAYED PRESSURE URTICARIA?41
LATE-ONSET COMBINED IMMUNE DEFICIENCY IN A PATIENT WITH ADENOSINE DEAMINASE GENE MUTATION39
A PATIENT WITH KABUKI SYNDROME AND HYPOGAMMAGLOBULINEMIA DEVELOPS BURKITT LYMPHOMA38
RECURRENT LUNG INFECTIONS IN A HETEROZYGOUS CARRIER OF NOVEL NSMCE3 MUTATION.38
A UNIQUE CLINICAL PRESENTATION OF COMMON VARIABLE IMMUNODEFICIENCY: MALAKOPLAKIA OF RECTUM.37
P061 BENRALIZUMAB IS EFFECTIVE IN REDUCING ASTHMA EXACERBATIONS: RESULTS FROM THE ZEPHYR 2 STUDY34
P093 IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) 20% SOLUTION ADMINISTRATION IN PRIMARY IMMUNODEFICIENCY DISEASES: A RETROSPECTIVE CHART REVIEW34
SEVERE INFLAMMATORY RESPONSE SYNDROME AFTER TMP-SMX IN A HEALTHY PATIENT34
P070 EFFICACY OF BIOLOGIC THERAPIES IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA STRATIFIED BY BLOOD EOSINOPHIL COUNT34
A022 ON-DEMAND ORAL TREATMENT WITH KVD900 FOR HAE ATTACKS ACHIEVES RAPID EXPOSURE AND IMPROVES PATIENT OUTCOMES33
M007 DRESS REACTION TO ANAKINRA IN A PATIENT WITH SEVERE SYSTEMIC JUVENILE ARTHRITIS (SJIA)33
P196 PATIENT PERCEPTION OF TREATMENT WITH LONG-TERM DUPILUMAB MONOTHERAPY IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS33
0.1408360004425